학술논문

Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.
Document Type
Academic Journal
Source
American Journal of Cardiology (AM J CARDIOL), Jun2006; 97(12): 1778-1784. (7p)
Subject
Language
English
ISSN
0002-9149